WitrynaImprove it slides. 1. IMProved Reduction of Outcomes: Vytorin Efficacy International Trial A Multicenter, Double-Blind, Randomized Study to Establish the Clinical Benefit and Safety of Vytorin (Ezetimibe/Simvastatin Tablet) vs Simvastatin Monotherapy in High-Risk Subjects Presenting With Acute Coronary Syndrome. 2. Witryna21 maj 2015 · Trial of Short-Course Antimicrobial Therapy for Intraabdominal Infection R. G. Sawyer and Others In patients with complicated intraabdominal infection, is a short, fixed-duration course of...
Comparative clinical effectiveness and cost effectiveness of ... - BMJ
Witryna18 cze 2015 · The IMPROVE-IT Trial Video Summary of Original Article Jun 18, 2015 Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes C. P. Cannon … Witryna14 lis 2024 · Objective To assess the three year clinical outcomes and cost effectiveness of a strategy of endovascular repair (if aortic morphology is suitable, open repair if not) versus open repair for patients with suspected ruptured abdominal aortic aneurysm. Design Randomised controlled trial. Setting 30 vascular centres (29 in UK, one in … darwin diocese facebook
improve ترجمة و معنى كلمة improve تصريف الفعل
Witryna31 maj 2024 · In summary, the DANAMI-3 PRIMULTI trial provides further evidence that treatment of non-infarct related arteries discovered during STEMI is beneficial, and suggests that the use of FFR-guidance remains beneficial even in the recent ACS setting. The subsequent Compare-Acute trial showed similar findings. On the strength of … WitrynaThe results from IMPROVE-IT revalidated the concept that low-density lipoprotein cholesterol (LDL-C) levels are a clinically relevant treatment goal. This trial also … WitrynaIMPROVE-IT is the first trial that demonstrates a significant clinical benefit of a nonstatin hypolipidemic agent (ezetimibe) used in combination with statin (simvastatin) therapy … bitbucket workspace access